Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer is a type of cancer that originates in the pancreas and eventually spreads or metastasizes to other organs and tissues in the body. In simpler terms, it’s when pancreatic cancer cells move to different parts of the body, causing new tumors to grow.

Think of the pancreas as a place where the cancer starts, like a seed. But over time, these cancer cells can travel through the bloodstream or lymphatic system to other places in the body, like the liver, lungs, or even bones. When they settle in these new areas and start growing there, that’s when we call it Metastatic Pancreatic Cancer. Metastatic Pancreatic Cancer, often referred to as “Pancreatic Cancer that has spread,” occurs when cancer cells from the pancreas move to other body parts, forming new tumors.

Types

types of metastatic pancreatic cancer in plain English, providing detailed descriptions to help you comprehend this complex disease. We’ll also ensure our content is SEO-optimized for better visibility on search engines.

  1. Adenocarcinoma

Adenocarcinoma is the most common type of pancreatic cancer, accounting for around 90% of cases. This cancer starts in the cells that line the ducts of the pancreas, which are responsible for producing digestive juices. Over time, these cancerous cells can spread to nearby organs and lymph nodes. Adenocarcinoma is the most prevalent type of pancreatic cancer, making up 90% of cases, and it begins in the cells lining the pancreas ducts.

  1. Pancreatic Neuroendocrine Tumors (PNETs)

Pancreatic Neuroendocrine Tumors, or PNETs, are less common than adenocarcinoma but still important to understand. These tumors develop in the hormone-producing cells of the pancreas, known as islet cells. PNETs can be classified into two categories:

  • a. Functioning PNETs: These tumors produce hormones, such as insulin and glucagon, which can lead to hormonal imbalances in the body. Symptoms vary depending on the hormone involved.
  • b. Non-functioning PNETs: These tumors do not produce hormones and may not cause noticeable symptoms until they grow large enough to press on nearby organs.

Pancreatic Neuroendocrine Tumors (PNETs) are rarer than adenocarcinoma and arise from hormone-producing cells in the pancreas, either producing hormones (functioning) or remaining silent (non-functioning).

  1. Acinar Cell Carcinoma

Acinar cell carcinoma is a rare type of pancreatic cancer, accounting for less than 1% of cases. It originates in the acinar cells of the pancreas, which are responsible for producing digestive enzymes. This type of cancer tends to grow more slowly than adenocarcinoma and may have a better prognosis when caught early. Acinar cell carcinoma, though exceedingly rare (less than 1% of cases), originates in the pancreas’ digestive enzyme-producing cells and typically grows at a slower pace than adenocarcinoma.

  1. Squamous Cell Carcinoma

Squamous cell carcinoma of the pancreas is another rare form of pancreatic cancer. It begins in the flat, scale-like cells that line the pancreatic ducts. This type of cancer is often diagnosed at an advanced stage, making it challenging to treat. Squamous cell carcinoma, a rare variant, starts in the flat, scale-like cells lining the pancreas ducts, but it’s frequently detected at advanced stages, posing treatment challenges.

  1. Cystic Pancreatic Cancer

Cystic pancreatic cancer is a less common subtype that forms within cysts or fluid-filled sacs in the pancreas. These cysts can be precancerous, meaning they have the potential to develop into cancer over time. Cystic pancreatic cancer can be challenging to detect and diagnose until it reaches an advanced stage. Cystic pancreatic cancer is a less common type that arises within fluid-filled sacs in the pancreas, often remaining undetected until it advances.

  1. Colloid Carcinoma

Colloid carcinoma is an exceptionally rare type of pancreatic cancer. It is characterized by the production of a jelly-like substance within the tumor. This substance makes the cancer cells less aggressive compared to other types of pancreatic cancer, but it can still be life-threatening if not treated promptly. Colloid carcinoma, an exceptionally rare form, is identified by the production of a jelly-like substance within the tumor, which, while less aggressive, still poses a significant threat if left untreated.

  1. Adenosquamous Carcinoma

Adenosquamous carcinoma is a rare and aggressive type of pancreatic cancer that contains both glandular (adenocarcinoma) and squamous (squamous cell carcinoma) cancer cells. This combination makes it particularly challenging to treat. Adenosquamous carcinoma, a rare and aggressive type, contains both glandular and squamous cancer cells, making it a formidable challenge in terms of treatment.

  1. Undifferentiated Carcinoma

Undifferentiated carcinoma is a highly aggressive type of pancreatic cancer characterized by poorly differentiated cells. These cancer cells lack the normal features and structures of pancreatic tissue, making them difficult to classify. Undifferentiated carcinoma is an aggressive form where the cancer cells lack the usual features of pancreatic tissue, making it challenging to classify.

  1. Rhabdoid Carcinoma

Rhabdoid carcinoma is an extremely rare and aggressive subtype of pancreatic cancer. It is named for the distinctive rhabdoid cells found in the tumor. This type of cancer often has a poor prognosis and tends to spread rapidly. Rhabdoid carcinoma is an exceedingly rare and aggressive subtype featuring rhabdoid cells in the tumor, associated with a grim prognosis and rapid spread.

Causes

Potential causes of Metastatic Pancreatic Cancer, explained in plain English to make this complex topic more accessible.

  1. Tobacco Smoking: Smoking is a leading cause of pancreatic cancer. When you smoke, harmful chemicals enter your body and can damage the pancreas, increasing the risk of cancer.
  2. Age: As you get older, your risk of developing pancreatic cancer goes up. Most cases occur in people over 60.
  3. Family History: If someone in your family has had pancreatic cancer, your risk increases. It may be due to shared genetics or environmental factors.
  4. Genetic Mutations: Some inherited gene mutations, like BRCA1 and BRCA2, can raise the risk of pancreatic cancer.
  5. Chronic Pancreatitis: Long-term inflammation of the pancreas can lead to cancer. This inflammation can result from excessive alcohol use or other factors.
  6. Obesity: Being significantly overweight can increase your chances of developing pancreatic cancer.
  7. Diabetes: Chronic diabetes, especially type 2, is linked to an increased risk of pancreatic cancer.
  8. Diet High in Red Meat: Consuming large amounts of red meat, particularly processed meats, may elevate the risk.
  9. Excessive Alcohol Consumption: Heavy alcohol use over time can harm the pancreas and heighten the risk.
  10. Exposure to Chemicals: Certain workplace exposures, like to pesticides, may contribute to pancreatic cancer.
  11. Race and Ethnicity: African Americans are at a slightly higher risk than others, and reasons for this are still being studied.
  12. Gender: Men are somewhat more likely than women to develop pancreatic cancer.
  13. Blood Group: Some studies suggest that individuals with blood type A, B, or AB may have a higher risk.
  14. Diet Low in Fruits and Vegetables: A diet lacking in these foods may increase the likelihood of pancreatic cancer.
  15. High Fat Diet: Diets high in unhealthy fats may contribute to the development of this cancer.
  16. Gum Disease: Poor oral health and gum disease have been linked to a slightly higher risk.
  17. Excessive Iron in the Blood: A condition called hemochromatosis, which causes excess iron, can be a risk factor.
  18. Certain Medications: Some drugs, such as certain blood pressure medications, may be associated with a higher risk.
  19. Chronic Gastric Reflux: Acid reflux over many years may increase the risk of pancreatic cancer.
  20. Helicobacter pylori Infection: This bacterium in the stomach has been investigated as a possible risk factor.
  21. Liver Cirrhosis: Long-term liver damage, often due to alcohol or viral hepatitis, may elevate risk.
  22. Exposure to Asbestos: Some studies suggest a link between asbestos exposure and pancreatic cancer.
  23. Pancreatic Cysts: Certain types of cysts in the pancreas may increase the risk.
  24. HPV Infection: Some research has explored a potential connection between HPV and pancreatic cancer.
  25. Low Selenium Levels: Low levels of this mineral in the body might be associated with an increased risk.
  26. Radiation Exposure: High doses of radiation, such as for cancer treatment, may increase risk, but this is rare.
  27. Alcohol-Related Liver Disease: Conditions like alcoholic hepatitis and cirrhosis may contribute to the risk.
  28. Inflammatory Bowel Disease: Long-standing conditions like Crohn’s disease and ulcerative colitis may elevate risk.
  29. Estrogen Replacement Therapy: Some studies have suggested a link between long-term estrogen replacement therapy and increased risk.
  30. Occupational Exposures: Certain jobs, like those involving chemicals or heavy metals, might heighten the risk.

Symptoms

Common symptoms of metastatic pancreatic cancer in simple terms, providing easy-to-understand explanations for each symptom.

  1. Unexplained Weight Loss: If you’re losing weight without trying, it could be due to cancer affecting how your body processes nutrients.
  2. Jaundice: When your skin and eyes turn yellow, it might be a sign that the cancer is blocking the bile ducts, causing a buildup of bilirubin.
  3. Abdominal Pain: Persistent pain in your abdomen, often radiating to your back, could indicate the cancer is affecting nearby nerves and tissues.
  4. Loss of Appetite: If you’re feeling less hungry than usual and have a reduced desire to eat, cancer might be affecting your body’s metabolism.
  5. Nausea and Vomiting: Feeling queasy and throwing up might occur as cancer impacts your digestive system.
  6. Bloating: Experiencing abdominal bloating and discomfort could be due to the tumor affecting your digestive processes.
  7. Fatigue: Overwhelming tiredness that doesn’t improve with rest might be linked to cancer’s impact on your body’s energy production.
  8. Change in Stool: Noticeable changes in the color of your stool or its consistency could be a result of cancer’s effect on your digestive tract.
  9. New-Onset Diabetes: Developing diabetes out of the blue might be linked to the cancer affecting your pancreas, which plays a role in regulating blood sugar.
  10. Blood Clots: Cancer can increase your risk of blood clots, which might lead to pain, redness, and swelling in your legs.
  11. Itchy Skin: If your skin is intensely itchy, it could be due to cancer affecting the liver and causing a buildup of bile salts.
  12. Pale, Greasy Stools: Stools that are pale and floating might indicate issues with your pancreas and its role in breaking down fats.
  13. Back Pain: Persistent back pain, especially in the upper back, could be a result of the cancer spreading to the spine or nearby tissues.
  14. Enlarged Gallbladder or Liver: Feeling a lump or noticing swelling in the abdominal area might be due to the cancer affecting these organs.
  15. Difficulty Swallowing: Trouble swallowing could be caused by the cancer pressing on the esophagus or other nearby structures.
  16. Unexplained Blood Clots: Developing blood clots without a clear cause might be linked to the cancer’s effect on your blood’s clotting ability.
  17. Ascites: The buildup of fluid in the abdomen can occur due to cancer’s impact on the liver and surrounding areas.
  18. Lack of Energy: Feeling extremely tired and weak might be a result of cancer affecting your overall health.
  19. Yellow Skin: In addition to jaundice, your skin might take on a yellowish hue due to the cancer’s impact on liver function.
  20. Depression: Coping with cancer can lead to feelings of sadness and depression, which should be addressed alongside the physical symptoms.

Diagnosis

Essential diagnostic methods and tests for metastatic pancreatic cancer in plain, easy-to-understand language.

  1. Symptom Evaluation:
    • When someone experiences symptoms like unexplained weight loss, jaundice (yellowing of the skin and eyes), abdominal pain, and digestive issues, it’s essential to consult a doctor. These symptoms can be early indicators of pancreatic cancer.
  2. Physical Examination:
    • Your doctor will perform a thorough physical examination, feeling for any unusual lumps or changes in your abdomen.
  3. Blood Tests:
    • Blood tests can help detect substances in the blood that might be indicative of pancreatic cancer, such as elevated levels of bilirubin or liver enzymes.
  4. CA 19-9 Blood Test:
    • CA 19-9 is a tumor marker that can be elevated in pancreatic cancer. However, it’s not exclusive to this cancer type, so further testing is necessary.
  5. Imaging Tests:
    • Various imaging tests provide detailed pictures of the pancreas and surrounding areas. These include:
      • CT (Computed Tomography) Scan:
        • A CT scan combines X-rays to create cross-sectional images. It’s useful for identifying the location and size of tumors.
      • MRI (Magnetic Resonance Imaging):
        • MRI uses magnetic fields to produce detailed images, helping doctors visualize the pancreas and nearby structures.
      • Endoscopic Ultrasound (EUS):
        • EUS involves passing an ultrasound probe through an endoscope, allowing for high-resolution imaging of the pancreas.
      • PET (Positron Emission Tomography) Scan:
        • PET scans help identify areas with abnormal cell activity, indicating possible cancer spread.
  6. Biopsy:
    • A biopsy involves taking a tissue sample for examination under a microscope. This is the most definitive way to confirm cancer. There are different biopsy methods:
      • Fine Needle Aspiration (FNA):
        • A thin needle is inserted into the pancreas to remove a tissue sample.
      • Endoscopic Biopsy:
        • An endoscope is used to guide biopsy tools to collect tissue samples.
      • Surgical Biopsy:
        • During surgery, a portion of the pancreas is removed and examined.
  7. Endoscopic Retrograde Cholangiopancreatography (ERCP):
    • ERCP is a procedure combining endoscopy and X-rays to examine the bile ducts and pancreatic ducts for blockages or abnormalities.
  8. Laparoscopy:
    • In laparoscopy, a small camera is inserted through a tiny incision in the abdomen to visualize the pancreas and surrounding areas.
  9. Genetic Testing:
    • Genetic tests can identify hereditary factors that might increase the risk of pancreatic cancer. They can also help guide treatment decisions.
  10. Cytology:
    • Cytology involves studying cells for signs of cancer. This can be done through brushing or washing procedures during an endoscopy.
  11. Staging:
    • Staging determines the extent of cancer spread. Tests for staging include:
      • Lymph Node Biopsy:
        • Removal and examination of nearby lymph nodes to check for cancer cells.
      • Exploratory Surgery:
        • Surgery to explore the abdomen and check for cancer spread.
  12. Liver Function Tests:
    • These tests assess the health of the liver, which is commonly affected by pancreatic cancer metastasis.
  13. Tumor Markers:
    • Apart from CA 19-9, other tumor markers like CEA (Carcinoembryonic Antigen) can also be elevated in pancreatic cancer.
  14. Pancreatic Function Tests:
    • These tests evaluate how well the pancreas is functioning, as cancer can affect its ability to produce digestive enzymes.
  15. Biliary Stent Placement:
    • If a blockage is found in the bile ducts, a stent may be placed to relieve it and improve the flow of bile.
  16. Bone Scans:
    • To check for bone metastasis, bone scans can be performed. These scans highlight areas where cancer has spread to the bones.
  17. Thoracic CT Scan:
    • This specialized CT scan focuses on the chest area to detect any lung metastases.
  18. Angiography:
    • Angiography uses contrast dye and X-rays to visualize blood vessels near the pancreas.
  19. Elastography:
    • Elastography assesses tissue stiffness and can help in identifying tumors.
  20. MRCP (Magnetic Resonance Cholangiopancreatography):
    • MRCP is an MRI technique that specifically images the bile and pancreatic ducts.
  21. EGD (Esophagogastroduodenoscopy):
    • EGD is used to examine the upper digestive tract and may reveal signs of cancer.
  22. Percutaneous Transhepatic Cholangiography (PTC):
    • PTC helps visualize the bile ducts and can assist in placing stents or drains.
  23. Core Needle Biopsy:
    • Similar to FNA, a core needle biopsy obtains larger tissue samples for more detailed analysis.
  24. Venous Sampling:
    • Venous sampling assesses the blood flow and can detect abnormalities related to cancer.
  25. Immunohistochemistry:
    • This technique uses antibodies to identify specific proteins on cancer cells, aiding in diagnosis and treatment planning.
  26. Fine Needle Biopsy (FNB):
    • FNB is a variation of FNA that uses a larger needle to collect more tissue for analysis.
  27. ERCP with Biopsy:
    • In some cases, an ERCP can also be used to obtain biopsy samples.
  28. Laparoscopic Ultrasound:
    • Combining laparoscopy and ultrasound, this test provides detailed images of the abdomen.
  29. Sentinel Lymph Node Biopsy:
    • This procedure focuses on the first lymph nodes that cancer is likely to spread to, aiding in staging.
  30. Cyberknife Radiosurgery:
    • Cyberknife is a precise form of radiation therapy used to target tumors with minimal damage to surrounding tissues.

Treatment

Treatments for Metastatic Pancreatic Cancer in plain English, making it easy for patients and their families to understand.

1. Surgery: Surgery is a common treatment for early-stage pancreatic cancer. Surgeons remove the tumor and nearby tissues if necessary.

2. Chemotherapy: Chemotherapy involves the use of drugs to kill cancer cells. It can be given before or after surgery to shrink tumors or prevent their return.

3. Radiation Therapy: Radiation therapy uses high-energy rays to target and destroy cancer cells. It’s often used alongside surgery or chemotherapy.

4. Immunotherapy: Immunotherapy helps the immune system fight cancer. It’s a promising treatment for metastatic pancreatic cancer.

5. Targeted Therapy: Targeted therapy drugs focus on specific molecules involved in cancer growth. They are designed to be more precise than chemotherapy.

6. Palliative Care: Palliative care focuses on improving the quality of life for patients, managing symptoms, and providing emotional support.

7. Clinical Trials: Clinical trials test new treatments and therapies. Patients may consider participating in these trials if eligible.

8. Whipple Procedure: A complex surgery called the Whipple procedure can remove tumors from the head of the pancreas.

9. NanoKnife Ablation: This procedure uses electrical currents to destroy cancer cells. It’s a less invasive option for some patients.

10. Pancreatic Enzyme Replacement Therapy (PERT): PERT helps the body digest food by replacing enzymes that the pancreas can no longer produce.

11. Pain Management: Metastatic pancreatic cancer can cause pain, which can be managed with medications and other techniques.

12. Radiofrequency Ablation (RFA): RFA uses heat to destroy cancer cells. It’s often used in combination with other treatments.

13. CyberKnife Radiosurgery: This precise form of radiation therapy delivers high doses of radiation to cancer cells with minimal damage to healthy tissue.

14. Gemcitabine: Gemcitabine is a chemotherapy drug commonly used to treat pancreatic cancer.

15. FOLFIRINOX: A combination of chemotherapy drugs (5-FU, leucovorin, irinotecan, and oxaliplatin) is called FOLFIRINOX, and it’s effective for some patients.

16. Abraxane: Abraxane is another chemotherapy drug that can be used in the treatment of metastatic pancreatic cancer.

17. Erlotinib: Erlotinib is a targeted therapy drug that may be used in combination with chemotherapy.

18. Stereotactic Body Radiation Therapy (SBRT): SBRT delivers precise radiation to small tumors over a few days.

19. Nutrition Therapy: Nutrition therapy can help patients maintain their weight and strength during treatment.

20. Support Groups: Joining support groups can provide emotional and psychological support during the cancer journey.

21. Steroids: Steroids can help reduce inflammation and swelling caused by tumors.

22. Chemoradiation: Combining chemotherapy and radiation therapy can be more effective in some cases.

23. Nanoparticle Drugs: These innovative drugs can deliver chemotherapy directly to cancer cells, reducing side effects.

24. Tumor Ablation: Ablation techniques, like microwave or cryoablation, can destroy tumors without surgery.

25. Pain Blockers: Nerve blocks or medications can be used to alleviate pain.

26. Supportive Care: Supportive care focuses on managing symptoms like nausea, vomiting, and fatigue.

27. Hospice Care: Hospice care provides comfort and support to patients in the final stages of cancer.

28. Dietary Supplements: Certain supplements may be recommended to complement treatment and boost the immune system.

29. Pancreatic Stent Placement: Stents can help keep the bile duct or pancreatic duct open if a tumor is blocking them.

30. Tumor Embolization: This procedure blocks blood vessels supplying the tumor, reducing its blood flow and growth.

Medications

Drug treatments for Metastatic Pancreatic Cancer,

  1. Gemcitabine:
    • Gemcitabine is a chemotherapy drug that slows down the growth of cancer cells. It’s often used as the first-line treatment for metastatic pancreatic cancer.
  2. Abraxane:
    • Abraxane is another chemotherapy drug that is combined with gemcitabine to enhance its effectiveness. It works by stopping cancer cells from dividing.
  3. FOLFIRINOX:
    • FOLFIRINOX is a combination of chemotherapy drugs (5-FU, leucovorin, irinotecan, and oxaliplatin). It’s used when the cancer is advanced but hasn’t spread too far.
  4. Nab-Paclitaxel (Albumin-bound):
    • Nab-paclitaxel is a type of chemotherapy that is often used in combination with gemcitabine. It helps gemcitabine work better.
  5. 5-Fluorouracil (5-FU):
    • 5-FU is a chemotherapy drug that interferes with the growth of cancer cells. It can be used alone or with other treatments.
  6. Irinotecan:
    • Irinotecan is another chemotherapy drug that can be used when other treatments haven’t been effective. It works by slowing down the growth of cancer cells.
  7. Oxaliplatin:
    • Oxaliplatin is a chemotherapy drug that is sometimes used in combination with other drugs like 5-FU to treat metastatic pancreatic cancer.
  8. Capecitabine:
    • Capecitabine is an oral chemotherapy drug that’s often used when the cancer has spread to other parts of the body. It’s easier for some patients to take than traditional IV chemotherapy.
  9. Erlotinib:
    • Erlotinib is a targeted therapy drug that works by blocking the signals that cancer cells use to grow. It’s typically used with gemcitabine.
  10. Atezolizumab:
    • Atezolizumab is an immunotherapy drug that helps the body’s immune system fight cancer. It’s used in combination with other treatments for advanced pancreatic cancer.
  11. Pembrolizumab:
    • Pembrolizumab is another immunotherapy drug that may be used when other treatments haven’t worked. It helps the immune system attack cancer cells.
  12. Nivolumab:
    • Nivolumab is an immunotherapy drug that can be used to treat metastatic pancreatic cancer in some cases. It also works by boosting the body’s immune response.
  13. Larotrectinib:
    • Larotrectinib is a targeted therapy drug that targets a specific gene mutation found in some pancreatic cancers. It’s used in cases where this mutation is present.
  14. Entrectinib:
    • Entrectinib is another targeted therapy drug that may be used when Larotrectinib isn’t an option. It targets specific genetic abnormalities in cancer cells.
  15. Onivyde:
    • Onivyde is a chemotherapy drug often used in combination with fluorouracil and leucovorin. It’s used when other treatments haven’t been effective.
  16. Panitumumab:
    • Panitumumab is a targeted therapy drug that’s used in cases where the cancer has specific genetic changes. It works by blocking the signals that help cancer cells grow.
  17. Regorafenib:
    • Regorafenib is a targeted therapy drug that can slow down the growth of cancer cells. It’s used when other treatments have failed.
  18. Lenvatinib:
    • Lenvatinib is another targeted therapy drug that can be used to treat pancreatic cancer in combination with another drug called everolimus.
  19. Everolimus:
    • Everolimus is often used with lenvatinib to treat pancreatic cancer. It works by blocking certain proteins that help cancer cells grow.
  20. Talazoparib:
    • Talazoparib is a targeted therapy drug that can be used in cases where the cancer has a specific genetic mutation called a BRCA mutation.

Conclusion:

Metastatic Pancreatic Cancer can be overwhelming, but there are many treatment options available. It’s essential to work closely with your healthcare team to determine the best approach for your specific situation. Whether it’s surgery, chemotherapy, targeted therapy, or supportive care, these treatments aim to improve your quality of life and provide hope in the face of this challenging disease. Remember, you’re not alone, and there are various resources and support networks available to help you on your journey.

Disclaimer: Always seek the advice of a medical professional before trying any treatments. This guide is for general information purposes only.

References